Corrigendum to “MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis” (MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis (2013) 46(10–11) (918–925), (S0009912013000520) (10.1016/j.clinbiochem.2013.01.024));MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis

Clinical Biochemistry

Volumn 46, Issue 10-11, 2013, Pages 918-925

  Vannini, Ivan ^a   Fanini, Francesca ^a,b   Fabbri, Muller ^a,c  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Biomarkers; Chemotherapy; Lung cancer; MicroRNAs

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CISPLATIN; GEFITINIB; MICRORNA; MICRORNA 106A; MICRORNA 1254; MICRORNA 126; MICRORNA 140 3P; MICRORNA 145; MICRORNA 155; MICRORNA 182; MICRORNA 191; MICRORNA 192; MICRORNA 205; MICRORNA 21; MICRORNA 210; MICRORNA 214; MICRORNA 221; MICRORNA 23A; MICRORNA 25; MICRORNA 29; MICRORNA 30A; MICRORNA 30D; MICRORNA 31; MICRORNA 34A; MICRORNA 34C 5P; MICRORNA 374A; MICRORNA 486 5P; MICRORNA 499; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NONHUMAN; ONCOGENE; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 84886085558     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2018.11.014     Document Type: Erratum

References (30)

1. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science Oct 26 2001, 294(5543):853-858.
2. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A Mar 2 2004, 101(9):2999-3004.
3. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet Oct 2009, 10(10):704-714.
4. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA Feb 14 2006, 103(7):2257-2261.
5. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell Mar 2006, 9(3):189-198.
6. Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res Oct 15 2008, 68(20):8535-8540.
7. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A Oct 2 2007, 104(40):15805-15810.
8. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res Oct 2008, 18(10):997-1006.
9. Rabinowits G., Gerçel-Taylor C., Day J.M., Taylor D.D., Kloecker G.H. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer Jan 2009, 10(1):42-46.
10. Fabbri M., Paone A., Calore F., Galli R., Gaudio E., Santhanam R., et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A Jul 31 2012, 109(31):E2110-E2116.
11. Lu Y., Govindan R., Wang L., Liu P.Y., Goodgame B., Wen W., et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis May 2012, 33(5):1046-1054.
12. Tan X., Qin W., Zhang L., Hang J., Li B., Zhang C., et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res Nov 1 2011, 17(21):6802-6811.
13. Landi M.T., Zhao Y., Rotunno M., Koshiol J., Liu H., Bergen A.W., et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res Jan 15 2010, 16(2):430-441.
14. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res Jun 1 2004, 64(11):3753-3756.
15. Voortman J., Goto A., Mendiboure J., Sohn J.J., Schetter A.J., Saito M., et al. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res Nov 1 2010, 70(21):8288-8298.
16. Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol Apr 1 2010, 28(10):1721-1726.
17. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
18. Lebanony D., Benjamin H., Gilad S., Ezagouri M., Dov A., Ashkenazi K., et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from non-squamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27:2030-2037.
19. Du L., Schageman J.J., Irnov Girard L., Hammond S.M., Minna J.D., Gazdar A.F., et al. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. J Exp Clin Cancer Res 2010, 29:75.
20. Vosa U., Vooder T., Kolde R., Fischer K., Valk K., Tonisson N., et al. Identification of miR-374a as a prognostic marker for survival in patients with early-stage non small cell lung cancer. Genes Chromosomes Cancer 2011, 50:812-822.
21. Arora S., Ranade A.R., Tran N.L., Nasser S., Sridhar S., Korn R.L., et al. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 2011, 129:2621-2631.
22. Nasser S., Ranade A.R., Sridhar S., Haney L., Korn R.L., Gotway M.B., et al. Biomarkers associated with metastasis of lung cancer to brain predict patient survival. Int J Data Min Bioinform 2011, 5:287-307.
23. Jeong H.C., Kim E.K., Lee J.H., Lee J.M., Yoo H.N., Kim J.K. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep 2011, 4:383-387.
24. Keller A., Leidinger P., Borries A., Wendschlag A., Wucherpfennig F., Scheffler M., et al. miRNAs in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353.
25. Leidinger P., Keller A., Borries A., Huwer H., Rohling M., Huebers J., et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011, 74:41-47.
26. Keller A., Leidinger P., Bauer A., El Sharawy A., Haas J., Backes C., et al. Toward the blood-borne miRNome of human diseases. Nat Methods 2011, 8:841-843.
27. Chen X., Hu Z., Wang W., Ba Y., Ma L., Zhang C., et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non invasive biomarkers for non small cell lung cancer diagnosis. Int J Cancer Jun 2012, 2. [Epub ahead of print].
28. Foss K.M., Sima C., Ugolini D., Neri M., Allen K.E., Weiss G.J. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol Mar 2011, 6(3):482-488.
29. Shen J., Todd N.W., Zhang H., Yu L., Lingxiao X., Mei Y., et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011, 91:579-587.
30. Keller A., Leidinger P., Gislefoss R., Haugen A., Langseth H., Staehler P., et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol May-Jun 2011, 8(3):506-516.